These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34276013)

  • 1. How to Estimate the Optimal Heart Rate in Patients with Heart Failure with Preserved Ejection Fraction.
    Izumida T; Imamura T; Fukui T; Koi T; Ueno Y; Hori M; Nakagaito M; Tanaka S; Kataoka N; Ushijima R; Nakamura M; Sobajima M; Fukuda N; Ueno H; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):816-820. PubMed ID: 34276013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to consider target heart rate in patients with systolic heart failure.
    Izumida T; Imamura T; Nakamura M; Fukuda N; Kinugawa K
    ESC Heart Fail; 2020 Oct; 7(5):3231-3234. PubMed ID: 32592292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomized placebo-controlled trial.
    Komajda M; Isnard R; Cohen-Solal A; Metra M; Pieske B; Ponikowski P; Voors AA; Dominjon F; Henon-Goburdhun C; Pannaux M; Böhm M;
    Eur J Heart Fail; 2017 Nov; 19(11):1495-1503. PubMed ID: 28462519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure.
    Imamura T; Kinugawa K
    Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine.
    Hori M; Imamura T; Narang N; Kinugawa K
    Intern Med; 2021 Dec; 60(24):3873-3877. PubMed ID: 34148961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic nature of pulmonary artery systolic pressure in decompensated heart failure with preserved ejection fraction: role of functional mitral regurgitation.
    Ennezat PV; Maréchaux S; Bouabdallaoui N; Le Jemtel TH
    J Card Fail; 2013 Nov; 19(11):746-52. PubMed ID: 24263118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial strain in heart failure with preserved ejection fraction.
    Aung SM; Güler A; Güler Y; Huraibat A; Karabay CY; Akdemir I
    Herz; 2017 Apr; 42(2):194-199. PubMed ID: 27352132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure.
    Izumida T; Imamura T; Ueno Y; Tanaka S; Kataoka N; Nakamura M; Kinugawa K
    Heart Vessels; 2021 Nov; 36(11):1688-1693. PubMed ID: 33956182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different implication of elevated B-type natriuretic peptide level in patients with heart failure with preserved ejection fraction and in those with reduced ejection fraction.
    Ishigaki T; Yoshida T; Izumi H; Fujisawa Y; Shimizu S; Masuda K; Asanuma T; Okabe H; Nakatani S
    Echocardiography; 2015 Apr; 32(4):623-9. PubMed ID: 25115860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the reliability of E/E' to estimate pulmonary capillary wedge pressure in heart failure patients with preserved ejection fraction versus those with reduced ejection fraction.
    Matsushita K; Minamishima T; Goda A; Ishiguro H; Kosho H; Sakata K; Satoh T; Yoshino H
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1497-502. PubMed ID: 26216649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart failure with preserved or reduced ejection fraction in patients treated with peritoneal dialysis.
    Wang AY; Wang M; Lam CW; Chan IH; Lui SF; Sanderson JE
    Am J Kidney Dis; 2013 Jun; 61(6):975-83. PubMed ID: 23474006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of heart rate optimization in patients with heart failure.
    Hori M; Imamura T; Kinugawa K
    J Cardiol Cases; 2021 Apr; 23(4):163-165. PubMed ID: 33841593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
    Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
    Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W; Holland DJ; Rojek A; Wright L; Przewlocka-Kosmala M; Marwick TH
    J Am Coll Cardiol; 2013 Oct; 62(15):1330-8. PubMed ID: 23916925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.